Prelude Therapeutics, Inc. (PRLD)
4.33
-0.17
(-3.78%)
USD |
NASDAQ |
May 21, 16:00
4.33
0.00 (0.00%)
After-Hours: 16:26
Prelude Therapeutics EPS Diluted (Quarterly) : -0.1258 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -0.3639 |
| Sana Biotechnology, Inc. | -0.1705 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.38M |
| Revenue (Quarterly) | 4.58M |
| Total Expenses (Quarterly) | 14.96M |
| Enterprise Value | 294.57M |
| Gross Profit Margin (Quarterly) | 91.46% |
| Profit Margin (Quarterly) | -226.7% |
| Earnings Yield | -24.42% |
| Normalized Earnings Yield | -24.42 |